Frontiers Outcome Measures in Clinical Trials of Patients With

Frontiers Outcome Measures in Clinical Trials of Patients With

Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19

PDF) Optimizing Cognitive Assessment Outcome Measures for Alzheimer's Disease by Matching Wordlist Memory Test Features to Scoring Methodology

Acupuncture for musculoskeletal pain: A meta-analysis and meta-regression of sham-controlled randomized clinical trials

Implementing Patient-Reported Outcome Measures in Clinical Breast Cancer Care: A Systematic Review - ScienceDirect

Incidence and Long-term Functional Outcome of Neurologic Disorders in Hospitalized Patients With COVID-19 Infected With Pre-Omicron Variants

PDF) Validation of Motor Outcome Measures in Myotonic Dystrophy Type 2

Clinical Trial Participants' Views of the Risks and Benefits of Data Sharing

Wearable device and smartphone data quantify ALS progression and may provide novel outcome measures

Frontiers Outcome Measures in Cancer Rehabilitation: Pain, Function, and Symptom Assessment

Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial - The Lancet Respiratory Medicine

Frontiers Using Patient-Reported Outcome Measures for Improved Decision-Making in Patients with Gastrointestinal Cancer – the Last Clinical Frontier in Surgical Oncology?

Full article: Clinical development on the frontier: gene therapy for duchenne muscular dystrophy

Frontiers Measurement tools to assess activities of daily living in patients with Parkinson's disease: A systematic review